Vestcor Inc increased its stake in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 98.2% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 27,423 shares of the medical research company's stock after purchasing an additional 13,588 shares during the period. Vestcor Inc's holdings in Agilent Technologies were worth $3,208,000 as of its most recent SEC filing.
Several other hedge funds have also added to or reduced their stakes in A. Geode Capital Management LLC grew its stake in shares of Agilent Technologies by 0.8% during the 4th quarter. Geode Capital Management LLC now owns 7,002,671 shares of the medical research company's stock worth $938,291,000 after acquiring an additional 53,992 shares in the last quarter. Pictet Asset Management Holding SA increased its stake in Agilent Technologies by 2.5% in the 1st quarter. Pictet Asset Management Holding SA now owns 5,341,870 shares of the medical research company's stock valued at $624,888,000 after buying an additional 128,131 shares during the last quarter. Deutsche Bank AG lifted its position in Agilent Technologies by 0.9% during the 4th quarter. Deutsche Bank AG now owns 4,436,700 shares of the medical research company's stock worth $596,026,000 after buying an additional 38,348 shares in the last quarter. Northern Trust Corp boosted its stake in shares of Agilent Technologies by 12.3% during the 4th quarter. Northern Trust Corp now owns 4,192,790 shares of the medical research company's stock worth $563,259,000 after buying an additional 457,713 shares during the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in shares of Agilent Technologies by 9.6% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,231,981 shares of the medical research company's stock valued at $434,184,000 after acquiring an additional 283,445 shares in the last quarter. Institutional investors and hedge funds own 87.41% of the company's stock.
Insider Transactions at Agilent Technologies
In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,508 shares of the firm's stock in a transaction dated Tuesday, July 1st. The stock was sold at an average price of $117.44, for a total transaction of $177,099.52. Following the transaction, the chief executive officer directly owned 37,448 shares in the company, valued at $4,397,893.12. This trade represents a 3.87% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 0.26% of the company's stock.
Wall Street Analyst Weigh In
Several analysts recently issued reports on A shares. Jefferies Financial Group dropped their target price on Agilent Technologies from $135.00 to $116.00 and set a "hold" rating on the stock in a report on Monday, April 21st. Wall Street Zen upgraded shares of Agilent Technologies from a "hold" rating to a "buy" rating in a report on Saturday, June 28th. Wells Fargo & Company cut their price target on shares of Agilent Technologies from $155.00 to $135.00 and set an "overweight" rating for the company in a research note on Thursday, April 17th. Barclays lifted their price objective on shares of Agilent Technologies from $115.00 to $125.00 and gave the company an "equal weight" rating in a research report on Tuesday, June 24th. Finally, Leerink Partners lifted their price target on Agilent Technologies to $135.00 and gave the stock a "buy" rating in a report on Friday, May 30th. Six investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $139.77.
View Our Latest Report on Agilent Technologies
Agilent Technologies Trading Up 0.9%
NYSE:A traded up $1.02 on Monday, hitting $114.52. 653,505 shares of the stock were exchanged, compared to its average volume of 2,021,158. The stock has a fifty day moving average of $117.08 and a 200-day moving average of $120.47. Agilent Technologies, Inc. has a fifty-two week low of $96.43 and a fifty-two week high of $153.84. The company has a current ratio of 2.09, a quick ratio of 1.60 and a debt-to-equity ratio of 0.55. The stock has a market cap of $32.53 billion, a PE ratio of 28.28, a PEG ratio of 3.44 and a beta of 1.22.
Agilent Technologies (NYSE:A - Get Free Report) last issued its quarterly earnings results on Wednesday, May 28th. The medical research company reported $1.31 EPS for the quarter, beating analysts' consensus estimates of $1.26 by $0.05. The firm had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.63 billion. Agilent Technologies had a return on equity of 25.92% and a net margin of 17.59%. Agilent Technologies's revenue for the quarter was up 6.0% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.22 earnings per share. As a group, equities analysts expect that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.
Agilent Technologies Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Wednesday, July 23rd. Shareholders of record on Tuesday, July 1st were issued a dividend of $0.248 per share. This represents a $0.99 annualized dividend and a yield of 0.9%. The ex-dividend date was Tuesday, July 1st. Agilent Technologies's payout ratio is presently 24.44%.
About Agilent Technologies
(
Free Report)
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.
Featured Articles
Before you consider Agilent Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilent Technologies wasn't on the list.
While Agilent Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
